Artificial Intelligence in Drug Discovery and Development: Emerging Technologies and Applications
DIA members: Sign in below to see content options. Not a member? Enjoy this preview, then see below to join DIA today!
Volume 90%
Press shift question mark to access a list of keyboard shortcuts
Keyboard Shortcuts
play/pause
increase volume
decrease volume
seek forwards
seek backwards
toggle captions
toggle fullscreen
mute/unmute
seek to %
SPACE
↑
↓
→
←
c
f
m
0-9
Read Full Transcript Access Interactive Transcript Listen and Download
Key Takeaways
- Quantum computing tools have the potential to address many early-phase biopharmaceutical challenges such as reaction rate prediction, combinatorial optimization, and accurate simulation of atoms and molecules.
- Metabolomics—an emerging field that analyzes metabolites to determine their biological function—can be enhanced with AI-based data processing and analysis to better understand disease pathway activity and identify appropriate interventions.
- In addition to helping identify digital biomarkers to power new and less fragile endpoints, AI-based approaches could influence a number of clinical research functions from protocol design and patient identification to endpoint selection and process automation.
Member Benefits
- Full Video, Transcript and Audio-only Version Available